北京市昌平区2型糖尿病患者骨质疏松现况及其影响因素研究

doi:10.12183/j.scjpm.2022.0934

摘要/Abstract

摘要： 目的探讨北京市昌平区2型糖尿病（T2DM）患者骨质疏松现况及其影响因素。方法 2020年10月在北京市昌平区16个街镇社区服务中心中招募T2DM患者作为调查对象,对符合研究条件的T2DM患者进行资料收集、体格检查、血生化指标检测及骨密度检测。采用描述性分析方法对T2DM患者骨质疏松发生情况进行分析,并采用单、多因素分析方法对T2DM患者骨质疏松发生影响因素进行分析。结果本研究招募符合研究条件且数据有效的T2DM患者2 126例,年龄22~76岁,病程以1~9年为主,占68.53%。2 126例T2DM患者骨质疏松发生率为10.11%。多因素Logistic回归分析结果显示,年龄（OR=2.512）、病程（OR=1.956）、BMI（OR=0.399）、吸烟（OR=2.895）、体育锻炼（OR=0.459）、血糖监测情况（OR=2.533）、糖化血红蛋白（HbA1c）水平（OR=3.517）、甲状旁腺激素水平（PTH）（OR=2.777）、碱性磷酸酶（ALP）水平（OR=3.452）、25羟维生素D[25（OH）D]水平（OR=1.982）均为T2DM病例合并骨质疏松的影响因素。结论北京市昌平区T2DM患者骨质疏松发生风险较高,其影响因素包括年龄、病程、BMI、吸烟、体育锻炼情况、血糖监测情况、HbA1c、PTH、ALP、25（OH）D水平,据此完善临床防治体系,有利于降低T2DM患者骨质疏松发生风险。

关键词: 骨质疏松, 2型糖尿病, 骨密度, 影响因素

Abstract: Objective To investigate the status and influencing factors of osteoporosis in patients with type 2 diabetes mellitus （T2DM） in Changping District, Beijing. Methods In October 2020, T2DM patients were recruited as survey subjects in 16 community service centers in Changping District, Beijing. Data collection, physical examination, blood biochemical index detection, and bone mineral density detection were performed on T2DM patients who met the research conditions. The descriptive analysis method was used to analyze the incidence of osteoporosis in T2DM patients, and univariate and multivariate analysis methods were used to analyze the influencing factors of osteoporosis in T2DM patients. Results A total of 2 126 T2DM patients with valid data were recruited in this study, aged 22-76 years old, and the course of disease was mainly 1-9 years, accounting for 68.53%. The incidence of osteoporosis in 2 126 T2DM patients was 10.11%. The multivariate Logistic regression model showed that age （OR=2.512）, course of disease （OR=1.956）, body mass index （BMI）（OR=0.399）, smoking （OR=2.895）, physical exercise （OR=0.459）, blood glucose monitoring （OR=2.533）, glycosylated hemoglobin （HbA1c）（OR=3.517）, parathyroid hormone （PTH）（OR=2.777）, alkaline phosphatase （ALP）（OR=3.452）, 25-hydroxyvitamin D [25（OH）D] （OR=1.982） were influencing factors of osteoporosis in T2DM patients. Conclusion T2DM patients in Changping District of Beijing have a higher risk of osteoporosis, and the influencing factors include age, course of disease, BMI, smoking, physical exercise, blood glucose monitoring, HbA1c, PTH, ALP, and 25（OH）D levels. Improving the clinical prevention and treatment system will help reduce the risk of osteoporosis in T2DM patients.

Key words: Osteoporosis, Type 2 diabetes mellitus, Bone mineral density, Influencing factor

中图分类号:

R195

高坦, 刘梅娟, 邓微, 陈佳. 北京市昌平区2型糖尿病患者骨质疏松现况及其影响因素研究[J]. 华南预防医学, 2022, 48(8): 934-938.

GAO Tan, LIU Mei-juan, DENG Wei, CHEN Jia. Status and influencing factors of osteoporosis in patients with type 2 diabetes mellitus in Changping District, Beijing[J]. South China Journal of Preventive Medicine, 2022, 48(8): 934-938.

参考文献

[1] Karki R,Kodamullil AT,Hofmann-Apitius M.Comorbidity analysis between alzheimer's disease and type 2 diabetes mellitus (t2dm) based on shared pathways and the role of t2dm drugs[J].J Alzheimers Dis,2017,60(2):721-731.
[2] 闫彬源,张维璐,田敏,等.1996~2016年中国≥20岁成年人2型糖尿病患病率meta分析[J].中华老年多器官疾病杂志,2018,17(11):814-819.
[3] Zhang H,Shi X,Wang L,et al.Intramembranous ossification and endochondral ossification are impaired differently between glucocorticoid-induced osteoporosis and estrogen deficiency-induced osteoporosis[J]. Sci Rep,2018,8(1):3867.
[4] Raška IJ, Rašková M, Zikán V, et al.Prevalence and risk factors of osteoporosis in postmenopausal women with type 2 diabetes mellitus[J].Cent Eur J Public Health,2017,25(1):3-10.
[5] 刘菊,王志刚,赵辉,等.老年2型糖尿病患者合并骨质疏松症的危险因素分析[J].中国骨质疏松杂志,2019,25(2):256-258,262.
[6] Hsu JY,Cheng CY,Hsu CY.Type 2 diabetes mellitus severity correlates with risk of hip fracture in patients with osteoporosis[J].Neth J Med,2018,76(2):65-71.
[7] Xu H,Wang Z,Li X,et al.Osteoporosis and osteopenia among patients with type 2 diabetes aged ≥50: Role of sex and clinical characteristics[J].J Clin Densitom,2019,23(1):29-36.
[8] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中华糖尿病杂志,2018,10(1):4-67.
[9] 中国成人血脂异常防治指南修订联合委员会.中国成人血脂异常防治指南(2016年修订版)[J].中华全科医师杂志,2017,16(1):15-35.
[10] 中国医师协会内分泌代谢科医师分会,国家代谢性疾病临床医学研究中心.糖尿病分型诊断中国专家共识[J].中华糖尿病杂志,2022,14(2):120-139.
[11] 中华医学会骨质疏松和骨矿盐疾病分会.维生素D及其类似物临床应用共识[J].中华骨质疏松和骨矿盐疾病杂志,2018,11(1):1-19.
[12] 王毅. 甲状旁腺激素和25羟维生素D对2型糖尿病患者并发骨质疏松症的影响[J].安徽医药,2018,22(10):1901-1904.
[13] 李伟,孔卓,王志新,等.与正常人群比较2型糖尿病患者骨转换标志物特点及分析[J].中国骨质疏松杂志,2018,24(9):1160-1164.
[14] 中华医学会放射学分会骨关节学组,中国医师协会放射医师分会肌骨学组,中华医学会骨科学分会骨质疏松学组,等.骨质疏松的影像学与骨密度诊断专家共识[J].中国骨质疏松杂志,2020,26(9):1249-1256.
[15] Kaka B, Maharaj SS.Effect of rebound exercises and circuit training on complications associated with type 2 diabetes: Protocol for a randomized controlled trial[J].JMIR Res Protoc,2018,7(5):e124.
[16] Banerjee J, Nema V, Dhas Y, et al.Role of microRNAs in type 2 diabetes and associated vascular complications[J]. Biochimie,2017,139(1):9-19.
[17] 崔喜财,崔凯.2型糖尿病患者糖化血红蛋白、胰岛素和C肽水平与骨质疏松症的关系分析[J].国际医药卫生导报,2021,27(1):45-47.
[18] Chen Z, Zhao GH, Zhang YK,et al.Research on the correlation of diabetes mellitus complicated with osteoporosis with lipid metabolism, adipokines and inflammatory factors and its regression analysis[J]. Eur Rev Med Pharmacol Sci,2017,21(17):3900-3905.
[19] 裘静英,董志春,王璟.2型糖尿病患者发生骨质疏松症的危险因素分析[J].中国医师杂志,2021,23(9):1391-1395.
[20] Seyfizadeh N, Seyfizadeh N, Negahdar H, et al.ABO blood group and prevalence of osteoporosis and osteopenia in the elderly population: An Amirkola Health and Ageing Project (AHAP)-Based Study[J]. J Clin Densitom,2018,21(2):200-204.
[21] 陈玉倩,熊钰,李光琴,等.国内2型糖尿病合并骨质疏松疾病相关影响因素的Meta分析[J]. 现代预防医学,2019,46(20):3826-3830,3840.
[22] Abdulameer SA,Sahib MN, Sulaiman SAS.The Prevalence of osteopenia and osteoporosis among Malaysian type 2 diabetic patients using quantitative ultrasound densitometer[J]. Open Rheumatol J,2018,12(1):50-64.
[23] Adebayo FA, Itkonen ST, Öhman T, et al.Vitamin D intake, serum 25-hydroxyvitamin D status and response to moderate vitamin D3 supplementation:A randomised controlled trial in East African and Finnish women[J]. Br J Nutr,2018,119(4):431-441.